Literature DB >> 28245759

Theoretical Studies for Dendrimer-Based Drug Delivery.

Martiniano Bello1, Jonathan Fragoso-Vázquez2, José Correa-Basurto1.   

Abstract

BACKGROUND: Numerous theoretical studies have been performed to iteratively optimize the physicochemical properties such as dendrimer size and surface constituents in solution, as well as their molecular recognition properties for drugs, lipid membranes, nucleic acids and proteins, etc. Molecular modeling approaches such as docking and molecular dynamic (MD) simulations have supported experimental efforts by providing important insights into the structural properties of dendrimers in solution and possible binding properties of drugs at the atomic level.
METHOD: We review the utilization of molecular modelling tools to obtain insight into the study and design of dendrimers, with particular importance placed on the improvement of binding properties of dendrimers for their use as drug nanocarriers and to increase the water solubility properties and drug delivery.
RESULTS: The modeling studies discussed in this review have provided substantial insight into the physicochemical properties of dendrimers in solution, including solvent pH and counterion distribution, at the atomic level, as well as the elucidation of some of the key interactions in solution of unmodified and modified dendrimers with some drugs of pharmaceutics interest and biological systems such as nucleic acids, proteins and lipid membranes.
CONCLUSION: the described studies illustrate that whether simulations will be run at the all-atom or coarse-grained level, physicochemical conditions such as the type of force field, the treatment of electrostatics effects, counterion distribution, protonation state of dendrimers, and dendrimer concentrations which have been probed to play a crucial role in the structural behavior and binding properties must be prudently incorporated in the simulations. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Dendrimers; biomaterials; dendrimer-drug interaction; molecular docking; molecular dynamics; molecular recognition; nanocarriers.

Mesh:

Substances:

Year:  2017        PMID: 28245759     DOI: 10.2174/1381612823666170228142429

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Practical computational toolkits for dendrimers and dendrons structure design.

Authors:  Nuno Martinho; Liana C Silva; Helena F Florindo; Steve Brocchini; Teresa Barata; Mire Zloh
Journal:  J Comput Aided Mol Des       Date:  2017-09-15       Impact factor: 3.686

2.  F7 and topotecan co-loaded thermosensitive liposome as a nano-drug delivery system for tumor hyperthermia.

Authors:  Chunyang Du; Shuangshuang Li; Yuan Li; Hervé Galons; Na Guo; Yuou Teng; Yongmin Zhang; Mingyuan Li; Peng Yu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 3.  Applications and Limitations of Dendrimers in Biomedicine.

Authors:  Adriana Aurelia Chis; Carmen Dobrea; Claudiu Morgovan; Anca Maria Arseniu; Luca Liviu Rus; Anca Butuca; Anca Maria Juncan; Maria Totan; Andreea Loredana Vonica-Tincu; Gabriela Cormos; Andrei Catalin Muntean; Maria Lucia Muresan; Felicia Gabriela Gligor; Adina Frum
Journal:  Molecules       Date:  2020-09-01       Impact factor: 4.411

Review 4.  A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer.

Authors:  Hilla Mills; Ronald Acquah; Nova Tang; Luke Cheung; Susanne Klenk; Ronald Glassen; Magali Pirson; Alain Albert; Duong Trinh Hoang; Thang Nguyen Van
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-09       Impact factor: 2.650

5.  Rational design of novel, fluorescent, tagged glutamic acid dendrimers with different terminal groups and in silico analysis of their properties.

Authors:  Nuno Martinho; Liana C Silva; Helena F Florindo; Steve Brocchini; Mire Zloh; Teresa S Barata
Journal:  Int J Nanomedicine       Date:  2017-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.